Cannabis stocks surge on Trump's rumored Schedule 3 marijuana change. How high can pot shares get?
Briefly

Cannabis stocks surge on Trump's rumored Schedule 3 marijuana change. How high can pot shares get?
"On Thursday, multiple outlets reported that the Trump administration is considering reclassifying marijuana from its current level as a Schedule I drug to a Schedule III drug. The Washington Post was the first to report on the potential reclassification, citing six sources familiar with the matter. As with most things Trump does, he is expected to issue a reclassification directive via an executive order."
"If the reclassification goes ahead, marijuana would be reduced from a Schedule I classification level to a Schedule III. A Schedule I drug is any drug "with no currently accepted medical use and a high potential for abuse," according to the United States Drug Enforcement Administration (DEA). Drugs in this category include ecstasy, heroin, LSD, peyote, and, currently, marijuana, among others."
Multiple outlets reported the Trump administration is considering reclassifying marijuana from Schedule I to Schedule III. A Schedule I classification denotes drugs with no currently accepted medical use and a high potential for abuse; current Schedule I drugs include ecstasy, heroin, LSD, and peyote. A Schedule III classification denotes a moderate to low potential for physical and psychological dependence; current Schedule III drugs include anabolic steroids, ketamine, testosterone, and Tylenol with codeine. Reclassification would not legalize marijuana federally but would loosen restrictions and could benefit companies in the cannabis industry, causing several cannabis stocks to surge. A White House official said no final decision has been made.
Read at Fast Company
Unable to calculate read time
[
|
]